Sagi Abelson

11PUBLICATIONS
65CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 14, 2026
Blood-based epigenetic instability linked to human aging and disease.

Salman Basrai, Ido Nofech-Mozes, Rajesh Detroja

|Nov 11, 2025
Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.

Vincent Rondeau, Suraj Bansal, Marco M Buttigieg

|Jun 26, 2024
Chronic TNF in the aging microenvironment exacerbates Tet2 loss-of-function myeloid expansion.

Candice Quin, Erica N DeJong, Amy J M McNaughton

|Mar 06, 2024
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

Maria Agustina Perusini, Daniela Žáčková, Taehyung Kim

|Mar 24, 2023
Pan-cancer classification of single cells in the tumour microenvironment.

Ido Nofech-Mozes, David Soave, Philip Awadalla

Pageof 2